Hansard to 11 September 2026 · 28,928 contributions indexed · 1,439 MPs & peers
01 Topic · Healthcare
Vital Signs: Cancer
Change topic · 28 health and social care topics
Healthcare · 22
- Cancer
- Mental health
- Dementia
- Diabetes
- Maternity & neonatal
- Long Covid
- Heart disease & stroke
- Respiratory (asthma/COPD)
- Palliative & end of life care
- Assisted dying
- Children's health
- Rare diseases
- NHS waiting lists
- A&E & ambulance response
- GP access
- Dentistry access
- NHS & care workforce/staffing
- Health inequalities
- Public health & prevention
- Medical ethics & regulation
- Cosmetic procedures & aesthetics
- Plastic & reconstructive surgery
Who is shaping the debate on cancer: in Parliament, in the press, and among the experts the press turns to.
02 Who is talking · pick a lens
03 The signal · Where it is spoken from
607
of 1,439 MPs & peers have spoken on cancer since 9 July 2024 · 1,956 Commons contributions from 419 constituencies · latest sitting indexed 11 September 2026
Seats shaded by Hansard contributions on this topic. Lines join the 9 MPs in this list to their constituencies; peers have no seat and no line.
- 01—
Clive JonesSpokespersonLiberal Democrat · Wokingham · Commons · Liberal Democrat Spokesperson (Trade)240
- 02—
Ashley DaltonLabour · West Lancashire · Commons225
- 03—
Jim ShannonDemocratic Unionist Party · Strangford · Commons216
- 04—
Dr Caroline JohnsonShadowConservative · Sleaford and North Hykeham · Commons · Shadow Minister (Health and Social Care)174
- 05—
Baroness MerronMinisterLabour · House of Lords · Parliamentary Under-Secretary (Department of Health and Social Care)158
- 06—
Wes StreetingCabinetLabour · Ilford North · Commons · Secretary of State for Defence135
- 07—
Karin SmythMinisterLabour · Bristol South · Commons · Minister of State (Department of Health and Social Care)132
- 08—
Helen MorganSpokespersonLiberal Democrat · North Shropshire · Commons · Liberal Democrat Spokesperson (Health and Social Care)93
- 09—
Sir Keir StarmerLabour · Holborn and St Pancras · Commons84
- 10—
Dr Scott ArthurLabour · Edinburgh South West · Commons81
Score is a weighted Hansard contribution score for this topic since 9 July 2024. Portraits: UK Parliament Members API. Rank change (▲/▼) is vs. 7 days ago.
Hansard · weekly mentions
371 mentions in the last 8 sitting weeks, 227 in the 8 before
Recess weeks are not counted: sitting weeks are compared with sitting weeks, and the current week is left off until it is complete. Parliament was in recess 27 Jul to 30 Aug 2026. 2,704 mentions since 9 July 2024.
Press · articles per week
188 articles in 25 weeks, 92 of them in the last five
Source: Guardian archive, trade press and news search: a sample of coverage, not an exhaustive count. Weekly article counts to w/c 7 Sept; weeks not yet ingested are dropped rather than shown as zero.
Parliament · party split
Share of scored contributions
- Labour311 members53%
- Liberal Democrat82 members19%
- Conservative131 members16%
- Democratic Unionist Party7 members4%
- Others (13 groups)76 members8%
Labour members account for 53% of the scored contributions on this topic, across 17 party groups in both Houses.
Parliament · reach
Members who have spoken
607of 1,439 MPs & peers
42% of the roster has spoken on this topic since 9 July 2024: one square per member, 419 MPs (navy) and 188 peers (cobalt).
Briefing · Parliament
MPs and peers debate cancer waiting times, radiotherapy access and funding for lobular breast cancer research
- The Health Bill's Report Stage generated the most sustained cancer-specific argument. Tim Farron (Liberal Democrat, Westmorland and Lonsdale) and Grahame Morris (Labour, Easington) pressed new clauses that would have created a legal right to begin cancer treatment within 62 days of referral and established a national radiotherapy framework, with Morris noting that only 35% of UK cancer patients received radiotherapy as part of primary treatment. Minister Karin Smyth (Labour, Bristol South) declined to accept the new clauses, pointing to the national cancer plan and the national cancer board as the Government's preferred accountability mechanism.
- The Lobular Breast Cancer Moon Shot Project debate in Westminster Hall on 9 July saw cross-party calls for the Government to ringfence £20 million over five years for research into invasive lobular breast cancer, with John Milne (Liberal Democrat, Horsham) and others paying tribute to campaigner Dr Susan Michaelis on the first anniversary of her death. Minister Stephen Kinnock (Labour, Aberafan Maesteg) refused to commit to ringfencing, saying competitive peer-reviewed applications were the standard process, though he acknowledged he would follow up on the status of live research bids.
- At the final Commons sitting before recess, on 11 September, the Terminally Ill Adults (End of Life) Bill prompted Members with direct cancer experience to speak. Ashley Dalton (Labour, West Lancashire), who disclosed a stage 4 metastatic breast cancer diagnosis, said she had considered that dying quickly might be easier on her family. Dr Zubir Ahmed (Labour, Glasgow South West), a practising cancer surgeon, argued as a sceptic that the six-month prognosis threshold would take an 'unhealthy salience in every clinical conversation', while Dr Peter Prinsley (Labour, Bury St Edmunds and Stowmarket) and Andrew Lewin (Labour, Welwyn Hatfield) argued that some cancer deaths were so distressing that the Bill was necessary.
- Access to cancer treatment for people in rural and coastal areas came up repeatedly. Richard Quigley (Labour, Isle of Wight West) described residents abandoning treatment because of travel costs across the Solent. Ben Maguire (Liberal Democrat, North Cornwall) detailed constituents making six-hour round trips by bus for chemotherapy, and Dan Aldridge (Labour, Weston-super-Mare) noted his town had no radiotherapy machine despite its size, while Tom Gordon (Liberal Democrat, Harrogate and Knaresborough) highlighted that clinical research funding in Yorkshire was about a quarter of what London received.
- The debate on diethylstilbestrol on 29 June, led by Jessica Toale (Labour, Bournemouth West), raised concerns that routine cervical smear tests do not reliably detect the rare cancer associated with DES exposure, leaving affected women unprotected. Minister Preet Kaur Gill (Labour, Birmingham Edgbaston) confirmed the Department had commissioned the University of Exeter to conduct a systematic evidence review, and that the national clinical director for cancer had written to all cancer alliance leaders in December 2025 to raise awareness among clinicians.
Verbatim
I was told that I have stage 4 incurable metastatic breast cancer. I was overwhelmed with grief, fear and anxiety; I was scared of what was to come, and fearful of how it would impact my family and my loved ones. I was scared that I was going to get really poorly and thinking, "How will I cope? How will my family cope? How will I be cared for? How will I afford it? How badly will it hurt? How long will it last?"
Ashley Dalton · Labour, West Lancashire · Terminally Ill Adults (End of Life) Bill · 11 Sept 2026
Read in Hansard (opens in a new tab)In my practice, if a patient comes to see me with stage 4 colon cancer that has spread to their liver, the advent of immunotherapy means that I have an equal chance of telling them they have six months to live or six years to live. Under this law, when I meet that kind of patient, it is unclear to me, with the Supreme Court precedents around consent, whether I should be offering them immunotherapy and an assisted death at the same sitting.
Dr Zubir Ahmed · Labour, Glasgow South West · Terminally Ill Adults (End of Life) Bill · 11 Sept 2026
Read in Hansard (opens in a new tab)We know the international consensus is that around half of all cancer patients have an evidence-based indication for radiotherapy at some point in their treatment. We should be aware that here in the United Kingdom in 2021, the last date for which figures were available, only 35% of cancer patients received it as part of their primary treatment.
Grahame Morris · Labour, Easington · Health Bill · 8 Sept 2026
Read in Hansard (opens in a new tab)Current routine smear testing for cervical cancer is designed primarily to deal with and detect changes linked to HPV. It does not reliably detect clear cell adenocarcinoma—the rare cancer associated with DES exposure. That means many DES daughters may believe that they are being adequately screened, but in fact the very cancers for which they have an increased risk will not be picked up through the standard process.
Jessica Toale · Labour, Bournemouth West · Diethylstilbestrol: Intergenerational Impact · 29 Jun 2026
Read in Hansard (opens in a new tab)
AI-drafted from 197 Hansard contributions over 28 sitting days · 25 June 2026 to 11 September 2026 · No sittings were recorded between 24 July 2026 and 31 August 2026. · quotes are exact copies of the Hansard record, speakers taken from the record · generated 13 Sept 2026 · how briefings are made
Expert voices · press citations
The most quoted voices on this topic
40 of 189 expert voices, 82 citations across 5 groups. Click a group to open it as a lens on the map.
Clinicians
15 · 30 citationsOpen lens ↑- Prof Peter JohnsonNHS England4
- Professor Victoria Tzortziou BrownRoyal College of General Practitioners (RCGP)3
- Prof Kamila HawthorneRoyal College of General Practitioners (RCGP)3
- Professor Azeem MajeedProfessor of primary care and public health at Imperial College London2
- Fiona ThistlethwaiteThe Christie NHS Foundation Trust2
- Dr Rachna ShroffUniversity of Arizona Cancer Center2
- Ian AshpoleChester Zoo (North of England Zoological Society)2
- Kevin HarringtonThe Institute of Cancer Research, London2
- Prof Stefan SymeonidesUniversity of Edinburgh / Edinburgh Cancer Centre (NHS Lothian)2
- Professor Derek Rosarioconsultant urological surgeon and clinical advisor to the UK NSC2
- Professor Georgina LongMelanoma Institute Australia (MIA) / The University of Sydney / Royal North Shore Hospital2
- Dr Sue MannNHS England1
- Dr David CapehornGP and paediatrics specialist1
- Dr Alison WrightRoyal College of Obstetricians and Gynaecologists (RCOG)1
- Dr Stephen HardenThe Royal College of Radiologists1
Academics
14 · 26 citationsOpen lens ↑- Prof Montserrat García-ClosasThe Institute of Cancer Research, London3
- Prof Devi SridharUniversity of Edinburgh2
- Dr Juan Francoco-author, Heinrich Heine University Düsseldorf2
- Dr Nick Woodiersenior safety investigator at HSSIB2
- Dr Sowmiya MoorthieCancer Research UK2
- Kristian HelinThe Institute of Cancer Research, London2
- Nick Jamesprofessor of prostate and bladder cancer research at The Institute of Cancer Research, London2
- Peter SasieniProfessor of cancer epidemiology at Queen Mary University of London2
- Prof Chris ElliottQueen's University Belfast (Institute for Global Food Security)2
- Prof Peter Hajekco-author and director of the health and lifestyle research unit at Queen Mary2
- Rebecca SiegelAmerican Cancer Society2
- Dr Amanda Doyleprimary care director, NHS England1
- Prof Becky Freemantobacco control researcher, University of Sydney1
- Dr Juliet Usher-SmithDepartment of Public Health and Primary Care, University of Cambridge1
Sector leaders
9 · 24 citationsOpen lens ↑- Michelle MitchellCancer Research UK5
- Dr Ian WalkerCancer Research UK4
- Chiara De BiaseProstate Cancer UK4
- Fiona OsgunCancer Research UK3
- Dame Laura LeeMaggie's (Maggie Keswick Jencks Cancer Caring Centres Trust)2
- Naser TurabiCancer Research UK2
- Dr Simon VincentBreast Cancer Now2
- Amy RylanceProstate Cancer UK1
- Dr John HoldenChief medical officer, MDDUS1
Regulators & officials
1 · 1 citationOpen lens ↑- Sir Chris WhittyDepartment of Health and Social Care1
Unions
1 · 1 citationOpen lens ↑- Dr Clare BannonBritish Medical Association (BMA)1
Methodology
How Vital Signs ranks
Parliament. Every Hansard contribution on a topic since 9 July 2024 is scored by type and summed per member; the map colours each constituency by how often its MP has raised the topic. Peers sit in no constituency and are ranked but not mapped.
Press.Bylines rank journalists and quotations rank expert voices, across the Guardian archive and trade press Vital Signs has read. A voice’s pin marks its organisation’s base, never the person’s home.
Briefings. Drafted by an AI model from the underlying Hansard text or articles. Every quotation in a Parliament briefing is an exact copy of the Hansard record and linked to it; press quotations are as the linked articles reported them. The speaker is always taken from the record, not the model.